<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3696924&amp;fmt=gif">
Skip to main content

Timegate Instruments is selected for Testa Challenge 2024!

Timegate Instruments Ltd. is one of the companies selected to participate in the innovation challenge called Testa Challenge held yearly in Testa Center, Sweden. Timegate is honored to be selected to be a part of this prestigious event in its aim to revolutionize biopharmaceutical manufacturing by advanced bioprocess monitoring tools.

Timegate previously participated in the Testa Challenge in 2022, achieving outstanding results. We are honored to join again this year to showcase the latest developments of the Timegated® solution and accelerate the adoption of time-gated Raman in bioproduction. As part of this challenge, we will demonstrate our pioneering technology in both upstream and downstream processes, collaborating with leading industry experts to drive significant advancements in bioprocessing. 

Testa Challenge offers the selected participants an opportunity to integrate, test, and verify their innovations within a fully funded standard bioproduction workflow. Testa Center, in collaboration with Cytiva aims to accelerate the adoption of groundbreaking technologies in bioproduction. The Testa Challenge 2024 follows an industry standard procedure for producing monoclonal antibodies, aimed at generating intermediate materials for antibody drug conjugate (ADC) applications. 

Testa Center facility is a collaborative initiative between the Swedish government and Cytiva, aimed at fostering the growth of the life science industry and enhancing its manufacturing capabilities. Its primary goal is to bridge the gap between discovery and industrialization, facilitating the transition from innovative research to large-scale production. 

Stay tuned for updates in August as we kick off the exciting three-week-long event!

Share this article:

Related articles


Subscribe to our newsletter

Stay on top of the latest news and blogs by subscriping to our mailing list.